It has been shown that the inhibition of epidermal growth factor receptor 2 (HER2) expression leads to reduced expression of vascular endothelial growth factor A (VEGFA), ultimately resulting in lower angiogenesis and anti-cancer effects [120]. Here, VEGFA is linked to cancer.